Article info
PDFMultiple sclerosis
Research paper
Assessment of cancer risk with β-interferon treatment for multiple sclerosis
- Correspondence to Dr Elaine Kingwell, Faculty of Medicine (Neurology), UBC Hospital, 2211 Wesbrook mall, University of British Columbia, Vancouver, British Columbia, Canada V6T 2B5; elainejk{at}mail.ubc.ca
Citation
Assessment of cancer risk with β-interferon treatment for multiple sclerosis
Publication history
- Received November 12, 2013
- Revised January 24, 2014
- Accepted January 28, 2014
- First published March 4, 2014.
Online issue publication
March 05, 2018
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions